Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 19/20 | 0.58 |
| ▸ | PPARA | Q07869 | 12/20 | 0.58 |
| ▸ | PPARG | P37231 | 7/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6265434 | 0.87 | PPARD (0.71) | PPARDPPARAPPARGMEN1ALDH1A1 | |
| Gw501516 SCHEMBL21391885 | 0.87 | PPARD (0.71) | PPARDPPARAPPARGMEN1ALDH1A1 | |
| SCHEMBL6237599 | 0.78 | PPARD (0.82) | PPARDPPARAPPARGMAPTFFAR1 | |
| SCHEMBL3809841 | 0.78 | PPARD (0.65) | PPARDPPARAPPARGMEN1ALDH1A1 | |
| SCHEMBL6265968 | 0.78 | PPARD (0.60) | PPARDPPARAPPARGMEN1ALDH1A1 | |
| SCHEMBL6235983 | 0.78 | PPARD (0.83) | PPARDPPARAPPARG | |
| SCHEMBL6239544 | 0.78 | PPARD (0.83) | PPARDPPARAPPARGMEN1ALDH1A1 | |
| SCHEMBL12431568 | 0.76 | PPARD (0.64) | PPARDPPARAPPARGMEN1ALDH1A1 | |
| SCHEMBL6265961 | 0.76 | PPARD (0.70) | PPARDPPARAPPARGMEN1ALDH1A1 | |
| SCHEMBL13647570 | 0.76 | PPARD (0.82) | PPARDPPARAPPARGMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1189895-B8 | THIAZOLE AND OXAZOLE DERIVATIVES AND THEIR PHARMACEUTICAL USE | SMITHKLINE BEECHAM CORP (US) | 2005-11-09 | — | — | EP | claimed |
| EP-1189895-A1 | THIAZOLE AND OXAZOLE DERIVATIVES AND THEIR PHARMACEUTICAL USE | GLAXO GROUP LIMITED (GB) | 2002-03-27 | — | — | EP | claimed |
| WO-2001000603-A1 | THIAZOLE AND OXAZOLE DERIVATIVES AND THEIR PHARMACEUTICAL USE | GLAXO GROUP LIMITED (GB) | 2001-01-04 | — | — | WO | claimed |
| EP-1189895-B8 | THIAZOLE AND OXAZOLE DERIVATIVES AND THEIR PHARMACEUTICAL USE | SMITHKLINE BEECHAM CORP (US) | 2005-11-09 | — | — | EP | disclosed |
| EP-1324773-A2 | USE OF A PPAR DELTA ACTIVATOR IN THE TREATMENT OF DISEASES RELATED TO NO INHIBITION OR TNF INHIBITION | GLAXO GROUP LIMITED (GB) | 2003-07-09 | — | — | EP | disclosed |
| EP-1324774-A2 | USE OF A PPAR DELTA ACTIVATOR FOR TREATING INFLAMMATORY CONDITIONS | GLAXO GROUP LIMITED (GB) | 2003-07-09 | — | — | EP | disclosed |
| WO-2002028434-A2 | USE OF A PPAR DELTA ACTIVATOR FOR TREATING INFLAMMATORY CONDITIONS | GLAXO GROUP LIMITED (GB) | 2002-04-11 | — | — | WO | disclosed |
| WO-2002028433-A2 | USE OF A PPAR DELTA ACTIVATOR IN THE TREATMENT OF DISEASES RELATED TO NO INHIBIT ION OR TNF INHIBITION | GLAXO GROUP LIMITED (GB) | 2002-04-11 | — | — | WO | disclosed |
| EP-1189895-A1 | THIAZOLE AND OXAZOLE DERIVATIVES AND THEIR PHARMACEUTICAL USE | GLAXO GROUP LIMITED (GB) | 2002-03-27 | — | — | EP | disclosed |
| WO-2001000603-A1 | THIAZOLE AND OXAZOLE DERIVATIVES AND THEIR PHARMACEUTICAL USE | GLAXO GROUP LIMITED (GB) | 2001-01-04 | — | — | WO | disclosed |